$5.85
NaN%
After Hours: Dec 24, 9:29 AM EDT
Comments
Loading...
Sinovac Biotech (NASDAQ:SVA) Stock, Earnings Estimates, EPS, And Revenue
Sinovac Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 16
EPS
$-0.160
Quarterly Revenue
$121.34M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$429.20M
Analyze the earnings history of Sinovac Biotech using advanced sorting and filters.
Data brought to you by Benzinga APIs
Sinovac Biotech (SVA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| FY | 2024-04-29 | $-1.32 | $-0.13 | -915.4 % |
Sinovac Biotech (SVA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| FY | 2024-04-29 | $448.27M | $0 | 100.0 % |
FAQ
When is Sinovac Biotech (NASDAQ:SVA) reporting earnings?
Sinovac Biotech (SVA) is scheduled to report earnings on April 16, 2025. The last reported earnings were for reported on August 16, 2024 for H1.
What were the latest earnings per share (EPS) for Sinovac Biotech (NASDAQ:SVA)?
The Actual EPS was $-0.16, which missed the estimate of $0.00.
What were Sinovac Biotech’s (NASDAQ:SVA) revenues?
The Actual Revenue was $121.3M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.